Items where authors include "Swart, AM"

Article

Clamp, AR, James, EC, McNeish, IA et al. (26 more authors) (2019) Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial. The Lancet, 394 (10214). pp. 2084-2095. ISSN 0140-6736

Stark, D orcid.org/0000-0002-6172-733X, Cook, A, Brown, J orcid.org/0000-0002-2719-7064 et al. (8 more authors) (2017) Quality of life with cediranib in relapsed ovarian cancer: The ICON6 phase 3 randomized clinical trial. Cancer, 123 (14). pp. 2752-2761. ISSN 0008-543X

Ledermann, JA, Embleton, AC, Raja, F et al. (16 more authors) (2016) Cediranib in patients with relapsed platinum-sensitive ovarian cancer (ICON6): a randomised, double-blind, placebo-controlled phase 3 trial. The Lancet, 387 (10023). pp. 1066-1074. ISSN 0140-6736

Oza, AM, Cook, AD, Pfisterer, J et al. (21 more authors) (2015) Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial. Lancet Oncology, 16 (8). pp. 928-936. ISSN 1470-2045

Abdel-Rahman, ME, Butler, J, Sydes, MR et al. (9 more authors) (2014) No socioeconomic inequalities in ovarian cancer survival within two randomised clinical trials. British Journal of Cancer, 111 (3). pp. 589-597. ISSN 0007-0920

Perren, TJ orcid.org/0000-0001-8472-8856, Swart, AM, Pfisterer, J et al. (23 more authors) (2011) A Phase 3 Trial of Bevacizumab in Ovarian Cancer. New England Journal of Medicine, 365. pp. 2484-2496. ISSN 0028-4793